(June 19, 2023, 11:08 AM EDT) -- ALEXANDRIA, Va. — In a recent petition for inter partes review (IPR), Bayer CropScience LP and Monsanto Co. (Bayer, collectively) tell the Patent Trial and Appeal Board that a patented transgenic soybean plant with cells containing recombinant DNA encoding should be canceled as anticipated and obvious....